ABITEC CORPORATION
501 W. 1^ST Ave.
Columbus, OH 43215 USA
W: www.abiteccorp.com

 

ABITEC develops and manufactures lipid-based excipients to enhance the bioavailability of poorly water-soluble and poorly permeable Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry. And now with the addition of Larodan, ABITEC has expanded its offerings to include high-purity research grade lipids.

New in 2025, ABITEC is offering Lipids for LNP Therapeutics.  With a catalogue of over 3000 lipid chemistries and the ability to customize and manufacture GMP lipids at both research and manufacturing scale, ABITEC is your partner of choice for customized functional lipids for the formulation of advanced drug delivery platforms, such as lipid nanoparticles.

ABISORB-DC^TM is ABITEC’s co-processed excipient system for the direct compression of liquid lipids and self-emulsifying drug delivery systems at industry tableting speeds.  ABISORB-DC can absorb up to 20-25% w/w of liquid lipids and then be subsequently compressed into tablets.

The ABISOL^TM Emulsion Preconcentrate Kit is a series of varying HLB, preformulated preconcentrates for the formulation of self-emulsifying drug delivery systems.  Fast track your lipid-based formulation with the ABISOL Emulsion Preconcentrate Kit.

ABITEC has an expansive portfolio of CAPMUL^® bioavailability enhancers, which are medium-chain mono- and di-glycerides and propylene glycol esters. These functional lipid excipients act as solubilizers and emulsifiers in oral, topical, transdermal, and parenteral drug delivery systems. CAPMUL excipients are recognized as the ideal starting point when formulating BCS Class II & IV (poorly water soluble) and BCS Class III & IV (poorly permeable) molecules.

CAPMUL-based formulations may be customized with the inclusion of CAPTEX^® medium-chain triglycerides and/or ACCONON^® non-ionic surfactants to formulate self-emulsifying drug delivery systems.

ABITEC manufactures high-quality lipid excipients for drug delivery applications in accordance with strict cGMP and applicable IPEC (International Pharmaceutical Excipient Council) guidelines in ISO-certified facilities. ABITEC’s customer-preferred portfolio of pharmaceutical excipients are monograph compliant, supported by drug master files (DMFs), and have precedence of use.

Dosage Forms Include: Oral, Injectable, Topical & Transdermal, Suppositories, Ophthalmic, and Inhaled

Application Include: Solubilization, Emulsification, Lubricating Dry Binder, Permeation Enhancement, Encapsulation, Controlled Release, and Self-Emulsifying Drug Delivery Systems

Lipids for LNP Therapeutics: https://www.abiteccorp.com/en/pharmaceutical/pharmaceutical-applications/lnp-therapeutics/

ABISORB-DC: https://www.abiteccorp.com/en/pharmaceutical/pharmaceutical-products/abisorb-dc/

ABISOL Emulsion Preconcentrate Kit: https://www.abiteccorp.com/en/landing-pages/abisol-emulsion-kits-available-now/

To Request a Sample: https://samples.abiteccorp.com/

LinkedIn: https://www.linkedin.com/company/1454313/admin/feed/posts

YouTube:  https://www.youtube.com/channel/UC9mfJCBOstRuc-i2Asgu4VQ